, Pfizer signed a framework agreement with Chinese company Zhejiang Hisun Pharmaceutical to set up a joint venture (JV) to develop, produce and commercialise generic pharmaceutical products in China...

more

prospects, and competition from emerging markets in Latin America. Key Trends & Developments .. In January 2012, workers at Pfizer’s Puerto Rico-based operations filed a lawsuit against the company...

more

Pharmacal Merck & Co., Inc. Starpharma Holdings limited Pfizer Inc....

more

Nordisk A/S, Pfizer Inc., Eli Lilly and Co. and Roche Holding Ltd. Key questions answered in this report: What will the market size be in 2015 and at what rate will it grow? What key trends is this market...

more

and medical devices market. Key players covered for the pharmaceutical market are Pfizer, Merck & Co., Roche, Abbott and Novartis. Key players covered for the medical devices market are Medtronic, Boston...

more

And Developments ?? In May 2012, Pfizer Indonesia director Widyaretna Buenastuti told the Jakarta Post the company intends to expand in the generic drug market in Indonesia and increase its market share...

more

from China and India, are becoming difficult to monitor due to technical advances by the producers, Kikule said. Counterfeit detecting machines have been provided to the NDA by Pfizer. A survey...

more

.9 billion and reflect a growing interest in licensing promising peptide and protein-based therapeutic molecules. They involve a number of major pharmaceutical companies, such as Pfizer, Sanofi, Merck & Co...

more

’s eteplirsen, for Duchenne muscular dystrophy: expected release of unblinded data from a Phase IIb trial. - Elelyso (taliglucerase alfa) for Gaucher disease, developed by Protalix in partnership with Pfizer...

more

Ingelheim GmbH, Royal DSM N.V. and BASF SE. Other vendors mentioned in the report are Bayer AG, Merck & Co., Mylan Inc., Hospira Inc., GlaxoSmithKline plc, Pfizer Inc., Eli Lilly and Co., Sanofi S...

more